"The future looks bright as far as a cure," one top HIV cure researcher told LGBTQ Nation.

Zimbabwe is one of the world's first countries to roll out lenacapavir, a long-acting HIV prevention drug that is ...

The Food and Drug Administration has approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections. The drug will be ...

In April 2025, we published a story with the headline: "Haunted by hopelessness: 12 Zambians share their stories as HIV drugs run out." It looked at the impact of President Trump's cuts to foreign aid ...

Long-acting injectable lenacapavir is emerging as one of themost powerful new tools in HIV prevention.The drug, also called LEN, is injected under the skin of the abdomen once every six months to ...

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday ...

With clinical studies demonstrating near-total protection, lenacapavir has been described by some health officials as a turning point for high-risk groups.

The U.S. announced Thursday that it will make an investment in the new HIV prevention drug called lenacapavir that’s been hailed as a “breakthrough” and a “game changer” by the medical community. The ...

Scientists at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology in Jupiter have received $15.7 million in four separate federal grants to help with their research over ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...